Tu J - Search Results

1

UBE2C is a diagnosis and therapeutic biomarker involved in immune infiltration of cancers including lung adenocarcinoma.

Cai D, Tian F, Wu M, Tu J, Wang Y. Cai D, et al. Among authors: tu j. J Cancer. 2024 Jan 27;15(6):1701-1717. doi: 10.7150/jca.92473. eCollection 2024. J Cancer. 2024. PMID: 38370368 Free PMC article.

2

Effectiveness of combined (131)I-chTNT and radiofrequency ablation therapy in treating advanced hepatocellular carcinoma.

Tu J, Ji J, Wu F, Wang Y, Zhang D, Zhao Z, Ying X. Tu J, et al. Cell Biochem Biophys. 2015 Mar;71(2):777-84. doi: 10.1007/s12013-014-0262-4. Cell Biochem Biophys. 2015. PMID: 25293788

3

Aspiration thrombectomy using a large-size catheter for acute lower extremity deep vein thrombosis.

Jia Z, Tu J, Zhao J, Ren B, Tian F, Wang K, Li S, Jiang G. Jia Z, et al. Among authors: tu j. J Vasc Surg Venous Lymphat Disord. 2016 Apr;4(2):167-71. doi: 10.1016/j.jvsv.2015.09.009. Epub 2015 Nov 21. J Vasc Surg Venous Lymphat Disord. 2016. PMID: 26993862 Free article.

4

Incidence and Outcomes of Inferior Vena Cava Filter Thrombus during Catheter-directed Thrombolysis for Proximal Deep Venous Thrombosis.

Jiang J, Tu J, Jia Z, Chen J, Cao H, Meng Q, Fuller TA, Tian F. Jiang J, et al. Among authors: tu j. Ann Vasc Surg. 2017 Jan;38:305-309. doi: 10.1016/j.avsg.2016.05.108. Epub 2016 Aug 12. Ann Vasc Surg. 2017. PMID: 27531087

5

The incidence and outcome of major complication following conventional TAE/TACE for hepatocellular carcinoma.

Tu J, Jia Z, Ying X, Zhang D, Li S, Tian F, Jiang G. Tu J, et al. Medicine (Baltimore). 2016 Dec;95(49):e5606. doi: 10.1097/MD.0000000000005606. Medicine (Baltimore). 2016. PMID: 27930585 Free PMC article.

6

Supplemental conventional transarterial embolization/chemoembolization therapy via extrahepatic arteries for hepatocellular carcinoma.

Huang Y, Jia Z, Tu J, Shen T, Tian F, Jiang G. Huang Y, et al. Among authors: tu j. J Cancer Res Ther. 2017;13(4):720-724. doi: 10.4103/jcrt.JCRT_993_16. J Cancer Res Ther. 2017. PMID: 28901321 Free article.

7

Piplartine suppresses proliferation and invasion of hepatocellular carcinoma by LINC01391-modulated Wnt/β-catenin pathway inactivation through ICAT.

Fan X, Song J, Zhao Z, Chen M, Tu J, Lu C, Wu F, Zhang D, Weng Q, Zheng L, Xu M, Ji J. Fan X, et al. Among authors: tu j. Cancer Lett. 2019 Sep 28;460:119-127. doi: 10.1016/j.canlet.2019.06.008. Epub 2019 Jun 14. Cancer Lett. 2019. PMID: 31207322

8

Circular RNA Circ100084 functions as sponge of miR‑23a‑5p to regulate IGF2 expression in hepatocellular carcinoma.

Yang J, Li Y, Yu Z, Zhou Y, Tu J, Lou J, Wang Y. Yang J, et al. Among authors: tu j. Mol Med Rep. 2020 Jun;21(6):2395-2404. doi: 10.3892/mmr.2020.11069. Epub 2020 Apr 10. Mol Med Rep. 2020. PMID: 32323783 Free PMC article.

9

LncRNA-SNHG6 promotes the progression of hepatocellular carcinoma by targeting miR-6509-5p and HIF1A.

Fan X, Zhao Z, Song J, Zhang D, Wu F, Tu J, Xu M, Ji J. Fan X, et al. Among authors: tu j. Cancer Cell Int. 2021 Mar 4;21(1):150. doi: 10.1186/s12935-021-01835-w. Cancer Cell Int. 2021. PMID: 33663502 Free PMC article.

10

A role for the NPM1/PTPN14/YAP axis in mediating hypoxia-induced chemoresistance to sorafenib in hepatocellular carcinoma.

Zhang D, Wu F, Song J, Meng M, Fan X, Lu C, Weng Q, Fang S, Zheng L, Tang B, Yang Y, Tu J, Xu M, Zhao Z, Ji J. Zhang D, et al. Among authors: tu j. Cancer Cell Int. 2022 Feb 8;22(1):65. doi: 10.1186/s12935-022-02479-0. Cancer Cell Int. 2022. PMID: 35135548 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,744 results

Search Page

Filters